TenderDekho Logo
GEM

Procurement Opportunity: BETAXOLOL 0.5 percent W per V ED BOTT OF 5 ML,ED PYRIMON CHLORAMPHENICOL 1 percent W per V plus,EYE in JABALPUR, MADHYA PRADESH

Bid Publish Date

20-Jun-2025, 6:29 pm

Bid End Date

11-Jul-2025, 7:00 pm

EMD

₹25,000

Location

JABALPUR , MADHYA PRADESH

Progress

RA
Issue20-Jun-2025, 6:29 pm
Reverse Auction23-Sep-2025, 10:00 am
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

291258

Category

LEVOSALBUTAMOL 50MCG plus BECLOMETASONE

Categories 24

INDUSTRIAL SALT OPHTHALMIC ANTIBIOTICS ANTIEMETICS ANTIFUNGAL DRUGS CHOLINERGIC DRUGS IMMUNOSUPPRESSANTS ACID BETAHISTINE ANTIMYCOTIC NASAL SPRAY AMEBICIDES ANTIPSYCHOTIC AGENTS FOLIC ACID ANTIPARASITIC DRUGS BENZODIAZEPINES TRANSITION METALS ANTICONVULSANTS COAGULANT DRUGS CORTICOSTEROIDS ANTIASTHMATIC DRUGS CIPROFLOXACIN BRIMONIDINE TARTRATE URINARY ANTI INFECTIVE

Public procurement opportunity for Indian Army BETAXOLOL 0. 5 percent W per V ED BOTT OF 5 ML, ED PYRIMON CHLORAMPHENICOL 1 percent W per V plus, EYE in JABALPUR, MADHYA PRADESH. Quantity: 291258 issued by. Submission Deadline: 11-07-2025 19: 00: 00. View full details and respond.

Documents 4

GeM-Bidding-7923919.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Bill of Quantities (BOQ) 94 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 BETAXOLOL 0.5 percent W per V ED BOTT OF 5 ML BETAXOLOL 0.5 percent W per V ED BOTT OF 5 ML 60 bott dglpproc2023 30
2 ED PYRIMON CHLORAMPHENICOL 1 percent W per V plus ED PYRIMON CHLORAMPHENICOL 1 percent W per V plus 60 bott dglpproc2023 30
3 EYE OINT CIPROFLOXACIN EYE OINT CIPROFLOXACIN 360 tube dglpproc2023 30
4 ED CIPROFLOXACIN plus DEXAMETHASONE ED CIPROFLOXACIN plus DEXAMETHASONE 900 bott dglpproc2023 30
5 ED FLUCONAZOLE 0.3 percent ED FLUCONAZOLE 0.3 percent 130 bott dglpproc2023 30
6 ED FLURBIPROFEN SODIUM 0.3 percent 5 ML ED FLURBIPROFEN SODIUM 0.3 percent 5 ML 960 bott dglpproc2023 30
7 GATIFLOXACIN 0.3 percent EYE DROP BOTT OF 5 ML E per D GATIFLOXACIN 0.3 percent EYE DROP BOTT OF 5 ML E per D 480 bott dglpproc2023 30
8 ED HOMATROPINE 2 percent W per V ED HOMATROPINE 2 percent W per V 120 bott dglpproc2023 30
9 INJ CALCIUM GLUCONATE 10 percent INJ CALCIUM GLUCONATE 10 percent 370 amp dglpproc2023 30
10 BRIMONIDINE TARTRATE 0.15 PERCENT OPHTHALMIC BRIMONIDINE TARTRATE 0.15 PERCENT OPHTHALMIC 1,500 bott dglpproc2023 30
11 ED LATANOPROST plus TIMOLOL ED LATANOPROST plus TIMOLOL 290 bott dglpproc2023 30
12 LOTEPREDENOL ETABONATE 0.5 percent BOTT OF 5 ML LOTEPREDENOL ETABONATE 0.5 percent BOTT OF 5 ML 1,150 bott dglpproc2023 30
13 NATAMYCIN 3 percent EYE DROPS IN 3 ML NATAMYCIN 3 percent EYE DROPS IN 3 ML 120 ml dglpproc2023 30
14 OFLOXACIN 0.3 percent BOTT OF 5 ML OFLOXACIN 0.3 percent BOTT OF 5 ML 540 no dglpproc2023 30
15 ED PILOCARPINE ED PILOCARPINE 200 bott dglpproc2023 30
16 SODIUM CHROMOGLYCATE 2 percent BOTT OF 10 ML SODIUM CHROMOGLYCATE 2 percent BOTT OF 10 ML 500 bott dglpproc2023 30
17 SODIUM CHLORIDE 5 percent EYE DROPS E per D SODIUM CHLORIDE 5 percent EYE DROPS E per D 670 bott dglpproc2023 30
18 SULPHACETAMIDE 20 percent W per V EYE DROPS SULPHACETAMIDE 20 percent W per V EYE DROPS 180 bott dglpproc2023 30
19 LULICONAZOLE CREAM LULICONAZOLE CREAM 3,000 tube dglpproc2023 30
20 EYE DROP TOBRAMYCIN 0.3 percent 5 ML EYE DROP TOBRAMYCIN 0.3 percent 5 ML 480 ml dglpproc2023 30
21 TROPICAMIDE 0.5 percent WITH 5 percent PHENYLEP TROPICAMIDE 0.5 percent WITH 5 percent PHENYLEP 120 bott dglpproc2023 30
22 TROPICAMIDE EYE SOLUTION 1 percent BOTT OF 5 ML TROPICAMIDE EYE SOLUTION 1 percent BOTT OF 5 ML 190 bott dglpproc2023 30
23 CHLORAMPHENICAL plus POLYMAXIN B SULPHATE plus CHLORAMPHENICAL plus POLYMAXIN B SULPHATE plus 30 bott dglpproc2023 30
24 ED ATROPINE ED ATROPINE 60 bott dglpproc2023 30
25 BIMATOPROST to 0.03 percent W per V EYE DROPS BIMATOPROST to 0.03 percent W per V EYE DROPS 300 bott dglpproc2023 30
26 RIPASUDIL 0.4 percent W per V EYE DROPS RIPASUDIL 0.4 percent W per V EYE DROPS 300 ml dglpproc2023 30
27 DORZOLAMIDE 2 percent W per V plus TIMOLOL 0.5 percent DORZOLAMIDE 2 percent W per V plus TIMOLOL 0.5 percent 430 bott dglpproc2023 30
28 PROPARACAINE 0.5 percent E per D PROPARACAINE 0.5 percent E per D 120 bott dglpproc2023 30
29 ED MOXIFLOXACIN 0.5 percent plus DEXAMETHASONE 0.1 ED MOXIFLOXACIN 0.5 percent plus DEXAMETHASONE 0.1 1,500 bott dglpproc2023 30
30 MOXIFLOXACIN OINT MOXIFLOXACIN OINT 150 tube dglpproc2023 30
31 BRIMONIDINE 0.2 percent plus TIMOLOL 0.5 percent EYE BRIMONIDINE 0.2 percent plus TIMOLOL 0.5 percent EYE 600 bott dglpproc2023 30
32 LATANOPROST 0.005 percent W per V EYE DROPS LATANOPROST 0.005 percent W per V EYE DROPS 360 ml dglpproc2023 30
33 ED NEPAFENAC 0.1 percent W per V ED NEPAFENAC 0.1 percent W per V 860 bott dglpproc2023 30
34 TACROLIMUS EYE OINT TACROLIMUS EYE OINT 270 tube dglpproc2023 30
35 ED BRINZOLAMIDE 1 percent ED BRINZOLAMIDE 1 percent 290 bott dglpproc2023 30
36 TAFLUPROST 0.0015 percent 2.5 ML TAFLUPROST 0.0015 percent 2.5 ML 180 tube dglpproc2023 30
37 MOMETASONE NASAL SPRAY MOMETASONE NASAL SPRAY 700 bott dglpproc2023 30
38 FLUTICASONE FUROATE 27.5 MCG NASAL SPRAY FLUTICASONE FUROATE 27.5 MCG NASAL SPRAY 1,350 no dglpproc2023 30
39 BETAHISTINE VERTIN 8 mg TAB BETAHISTINE VERTIN 8 mg TAB 24,100 nos dglpproc2023 30
40 ISOTONIC NASAL SPARY ISOTONIC NASAL SPARY 300 bott dglpproc2023 30
41 CINNARIZINE 25 mg TAB STUGERON CINNARIZINE 25 mg TAB STUGERON 8,800 nos dglpproc2023 30
42 PROCHLOROPERAZINE 5 mg TAB PROCHLOROPERAZINE 5 mg TAB 1,200 nos dglpproc2023 30
43 CLOTRIMAZOLE 1 percent W per V IP plus LIGNOCAINE 2 percent CLOTRIMAZOLE 1 percent W per V IP plus LIGNOCAINE 2 percent 360 bott dglpproc2023 30
44 EAR DROP CHLORAMPHENICOL 5 percent W per V CLOTRIMAZOLE EAR DROP CHLORAMPHENICOL 5 percent W per V CLOTRIMAZOLE 700 bott dglpproc2023 30
45 XYLOMETAZOLINE 10 ML NASAL DROP XYLOMETAZOLINE 10 ML NASAL DROP 1,500 bott dglpproc2023 30
46 SYP CEFACLOR 125 mg per 5 ML SYP CEFACLOR 125 mg per 5 ML 90 bott dglpproc2023 30
47 SYP PERACTIN CYPROHEPTADINE SYP PERACTIN CYPROHEPTADINE 600 bott dglpproc2023 30
48 SYP METRONIDAZOLE 60 ML SYP METRONIDAZOLE 60 ML 100 bott dglpproc2023 30
49 ONDANSETRON SYP 2 mg per 5 ML IN BOTT OF 30 ML ONDANSETRON SYP 2 mg per 5 ML IN BOTT OF 30 ML 48 bott dglpproc2023 30
50 SYP IRON WITH VITAMIN B 12 AND FOLIC ACID BOTTLE OF 200 ML SYP SYP IRON WITH VITAMIN B 12 AND FOLIC ACID BOTTLE OF 200 ML SYP 3,100 bott dglpproc2023 30
51 SYP SALBUTAMOL 100 ML SYP SALBUTAMOL 100 ML 30 bott dglpproc2023 30
52 ALPRAZOLAM 0.25 mg TAB ALPRAZOLAM 0.25 mg TAB 21,000 nos dglpproc2023 30
53 BUPROPION 150 mg TAB BUPROPION 150 mg TAB 2,100 nos dglpproc2023 30
54 BUSPIRONE HCL 10 mg TAB BUSPIRONE HCL 10 mg TAB 1,200 nos dglpproc2023 30
55 CHLORDIAZEPOXIDE 10 mg LIBRIUM TAB CHLORDIAZEPOXIDE 10 mg LIBRIUM TAB 3,600 nos dglpproc2023 30
56 CLONAZEPAM 0.5 mg TAB CLONAZEPAM 0.5 mg TAB 25,200 nos dglpproc2023 30
57 DOXEPIN 25 mg CAP DOXEPIN 25 mg CAP 3,800 nos dglpproc2023 30
58 CHLORPROMAZINE 25 MG TAB CHLORPROMAZINE 25 MG TAB 1,200 nos dglpproc2023 30
59 CLOMIPRAMINE 25 mg TAB CLOMIPRAMINE 25 mg TAB 3,000 nos dglpproc2023 30
60 CLOZAPINE 100 MG TAB CLOZAPINE 100 MG TAB 700 nos dglpproc2023 30
61 DULOXETINE 20 mg CAP DULOXETINE 20 mg CAP 19,800 nos dglpproc2023 30
62 DOXEPIN 75 mg CAP DOXEPIN 75 mg CAP 2,700 nos dglpproc2023 30
63 FLUOXETINE 20 mg TAB FLUOXETINE 20 mg TAB 6,000 nos dglpproc2023 30
64 FLUVOXAMINE 50MG TAB FLUVOXAMINE 50MG TAB 4,800 no dglpproc2023 30
65 HALOPERIDOL DECONATE 50 MG per ML INJ HALOPERIDOL DECONATE 50 MG per ML INJ 150 amp dglpproc2023 30
66 INJ HALOPERIDOL 5 MG SERENACE INJ HALOPERIDOL 5 MG SERENACE 90 amp dglpproc2023 30
67 HALOPERIDOL 5 mg TAB HALOPERIDOL 5 mg TAB 3,300 nos dglpproc2023 30
68 HALOPERIDOL SYP 2 mg per ML BOTT OF 30 ML HALOPERIDOL SYP 2 mg per ML BOTT OF 30 ML 60 amp dglpproc2023 30
69 IMIPRAMINE 25 mg TAB IMIPRAMINE 25 mg TAB 3,600 nos dglpproc2023 30
70 LORAZEPAM 1 mg TAB LORAZEPAM 1 mg TAB 8,600 nos dglpproc2023 30
71 MEMANTINE 10 mg TAB MEMANTINE 10 mg TAB 1,800 nos dglpproc2023 30
72 LITHIUM CARBONATE 300 mg CAP per TAB LITHIUM CARBONATE 300 mg CAP per TAB 6,600 nos dglpproc2023 30
73 MIRTAZAPINE 15 mg TAB MIRTAZAPINE 15 mg TAB 7,200 nos dglpproc2023 30
74 MEMANTINE 5 mg TAB MEMANTINE 5 mg TAB 6,300 nos dglpproc2023 30
75 ESCITALOPRAM 5 mg TAB ESCITALOPRAM 5 mg TAB 3,000 nos dglpproc2023 30
76 AMISULPRIDE 50 mg TAB AMISULPRIDE 50 mg TAB 300 nos dglpproc2023 30
77 ARIPIPRAZOLE 15 MG TAB ARIPIPRAZOLE 15 MG TAB 1,800 nos dglpproc2023 30
78 CLONAZEPAM 0.25 mg TAB CLONAZEPAM 0.25 mg TAB 29,700 nos dglpproc2023 30
79 CLOZAPINE 25 mg TAB CLOZAPINE 25 mg TAB 1,300 nos dglpproc2023 30
80 DESVENLAFAXINE 50 mg TAB DESVENLAFAXINE 50 mg TAB 4,900 nos dglpproc2023 30
81 DOTHIEPIN 75 mg TAB DOTHIEPIN 75 mg TAB 1,700 nos dglpproc2023 30
82 ETIZOLAM 0.5 mg TAB ETIZOLAM 0.5 mg TAB 5,100 nos dglpproc2023 30
83 RISPERIDONE 2 mg TAB RISPERIDONE 2 mg TAB 16,800 nos dglpproc2023 30
84 RISPERIDONE 1 MG per ML SYP IN BOTT OF 30 ML RISPERIDONE 1 MG per ML SYP IN BOTT OF 30 ML 60 ml dglpproc2023 30
85 ARIPIPRAZOLE 10 Nos TAB ARIPIPRAZOLE 10 Nos TAB 7,200 nos dglpproc2023 30
86 ATOMOXETINE 10 mg TAB ATOMOXETINE 10 mg TAB 1,500 nos dglpproc2023 30
87 FLUOXETINE 60 mg CAP FLUOXETINE 60 mg CAP 30 nos dglpproc2023 30
88 FLUVOXAMINE LUVOX 100 MG TAB FLUVOXAMINE LUVOX 100 MG TAB 600 nos dglpproc2023 30
89 OLANZAPINE 10 mg TAB OLANZAPINE 10 mg TAB 6,600 nos dglpproc2023 30
90 OLANZAPINE 5 mg TAB OLANZAPINE 5 mg TAB 11,600 nos dglpproc2023 30
91 RIVASTIGMINE 1.5 mg CAP RIVASTIGMINE 1.5 mg CAP 600 nos dglpproc2023 30
92 TRAZODONE 50 mg TAB TRAZODONE 50 mg TAB 1,800 nos dglpproc2023 30
93 VENLAFAXINE 75 mg TAB VENLAFAXINE 75 mg TAB 780 nos dglpproc2023 30
94 LEVOSALBUTAMOL 50MCG plus BECLOMETASONE LEVOSALBUTAMOL 50MCG plus BECLOMETASONE 2,280 no dglpproc2023 30

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Reverse Auction Schedule

Completed

Start

23-Sep-2025, 10:00 am

End

24-Sep-2025, 1:00 pm

Duration: 27 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Frequently Asked Questions

Key insights about MADHYA PRADESH tender market

What are the eligibility requirements for GEM/2025/B/6306075?

The eligibility requirements include being a registered entity as a pharmaceutical manufacturer or authorized dealer. Bidders must comply with all related regulations and standards, such as possessing the necessary certificates like GMP. Each bidder should demonstrate their ability to supply the medications as specified, ensuring adherence to regulatory requirements and maintaining high-quality standards.

What certificates are required for participating in this tender?

To participate in the tender, bidders must provide valid certificates including proof of registration as a pharmaceutical entity, GMP (Good Manufacturing Practices) certification, and any other relevant compliance documents. These certificates are crucial in certifying the quality and legitimacy of the medications.

How do I register for this tender, and what document formats are accepted?

Registration involves completing the designated tender application form, available within the tender documents. Accepted document formats include PDF and DOCX for all submissions. Bidders should ensure that all documents are clear, legible, and formatted according to the guidelines specified in the tender documentation.

What are the EMD and performance security requirements for this tender?

Each bidder must submit an Earnest Money Deposit (EMD) as specified in the tender documentation. The performance security requirements post-award will typically require a certain percentage of the total contract value to ensure compliance with contract terms. Details of the EMD and performance security terms will be provided in the tender guidelines.

What are the benefits for MSEs and startups in this tender?

While the tender does not specify unique benefits for Micro, Small, and Medium Enterprises (MSEs) or startups, it’s important for these entities to highlight their social impact and innovative approaches in their proposals. Bidders are encouraged to present qualifications aligned with the 'Make in India' initiative and local procurement rules to enhance their competitive advantage.